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Introduction
A genetic predisposition to cluster headache (CH) has long
been debated. Genetic epidemiological studies have
reported an increased risk of CH in relatives of CH
sufferers. The familial clustering supports a model of auto-
somal dominant inheritance with reduced penetrance.
Some candidate gene studies have been performed, detect-
ing associations with HCRTR2 and ADH4, but these have
been limited by small sample size. We have established a
large cohort of CH families in which we have previously
reported a genome-wide linkage scan, isolating a number of
putative linkage loci[1]. Despite this, a single causative gene
is yet to be identified, largely due to substantial genetic
heterogeneity.
Purpose
To further delineate the genetic architecture underlying
CH, we have used an exome sequencing strategy in a
subset of Northern European families.
Methods and results
Exome target enrichment and paired-end sequencing
were performed for ten probands. Annotated variants
were filtered to exclude known polymorphisms, leaving
a total of 1711 novel variants. Exome data from related
affected subjects were examined to limit the analysis to
variants segregating with the CH phenotype. Segregation
analysis by Sanger sequencing in all family members
reduced the candidate list to a total of 45 genes (range:
1-13 genes per pedigree). These genes are now being
screened in our extended cohort to provide further
insight into the role of each gene in CH pathogenesis.
Conclusion
Whilst exome sequencing for rare monogenic disorders is
now well-established, approaches to detect pathogenic
variation with complexities such as locus heterogeneity and
incomplete penetrance remain challenging. We have com-
bined exome and Sanger sequencing to isolate novel cod-
ing variation segregating across CH families, highlighting
the need for large homogeneous cohorts to elucidate the
molecular genetic basis of CH. The significance of these
variants in CH pathogenesis remains to be determined;
however these results provide further evidence for a poten-
tial genetic predisposition to this debilitating disorder.
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